6 win national pediatric medical device competition, share $250k in grants

The National Capital Consortium for Pediatric Device Innovation announced six winners in its annual “Make Your Medical Device Pitch for Kids!” competition, according to a statement Sept. 30 from Children’s National Hospital in Washington, D.C.

Advertisement

The winners, who will share $250,000 in grants funded by the FDA, are:

1. Cambridge, Mass.-based Adipomics for COVI-SPOT, a one-step COVID-19 test.

2. Beverly Hills, Mich.-based Biosense for the first working non-contract EKG.

3. Olathe, Kan.-based Innara Health for a biofeedback device to help newborn and premature infants improve feeding readiness

4. Melbourne, Australia-based Navi Medical Technologies for its non-invasive device providing real-time feedback of the central line tip location via ECG

5. South San Francisco-based Novonate for its secure umbilical catheter insertion site for neonates in the ICU.

6. Costa Mesa, Calif.-based Renata Medical for a growth stent to treat congenital narrowed lesions in neonatal patients

Read the full press release with footage of the pitch competition here.

More articles on orthopedics:
Appeals court reverses IU Health win in suit over near-fatal spine surgery
Dr. Ernest Braxton offers awake spinal fusion to patients in Colorado
Smith+Nephew agrees to $240M deal to acquire Integra LifeSciences’ extremity orthopedics line

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.